World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
57
Citations
9841
World Ranking
4396
National Ranking
374

Adam Strzelczyk publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Adam Strzelczyk sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 314 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Adam Strzelczyk D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Adam Strzelczyk sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 57 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Adam Strzelczyk is affiliated with Goethe University Frankfurt in Germany. Their research primarily focuses on medicine, with a substantial body of work spanning subfields such as psychiatry and mental health, pediatrics, perinatology and child health, cellular and molecular neuroscience, neurology, and genetics.

The main areas of scholarly contribution include epilepsy research and treatment, pharmacological effects and toxicity studies, neuroscience and neuropharmacology research, neonatal and fetal brain pathology, tuberous sclerosis complex research, metabolism and genetic disorders, and traumatic brain injury and neurovascular disturbances.

Frequent co-authors collaborating with Adam Strzelczyk include Felix Rosenow, Susanne Schubert-Bast, Laurent M. Willems, Susanne Knake, and Johann Philipp Zöllner.

Publications by Strzelczyk have appeared regularly in a select group of journals and venues, reflecting specialized interest in epilepsy and neurological conditions. The most common venues of publication are:

  • Epilepsy & Behavior
  • Epilepsia
  • Clinical Epileptology
  • Neurological Research and Practice
  • Zeitschrift für Epileptologie

Among recent papers associated with Strzelczyk are:

  • Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies, 2022, CNS Drugs
  • International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020), 2021, Frontiers in Human Neuroscience (authored by Adam D. Farmer but included in the dataset)
  • A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC), 2020, Orphanet Journal of Rare Diseases (authored by Johann Philipp Zöllner)
  • Reduced Rate of Inpatient Hospital Admissions in 18 German University Hospitals During the COVID-19 Lockdown, 2021, Frontiers in Public Health (authored by Lorenz A. Kapsner)
  • Comparison of minimally invasive and traditional surgical approaches for refractory mesial temporal lobe epilepsy: A systematic review and meta-analysis of outcomes, 2021, Epilepsia (authored by Konstantin Kohlhase)

Best Publications

  • Cost of epilepsy: a systematic review.

    Adam Strzelczyk;Jens Peter Reese;Richard Dodel;Hajo M Hamer

  • International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020).

    Adam D. Farmer;Adam Strzelczyk;Alessandra Finisguerra;Alexander V. Gourine

  • Costs, length of stay, and mortality of super‐refractory status epilepticus: A population‐based study from Germany

    Adam Strzelczyk;Adam Strzelczyk;Sonja Ansorge;Jana Hapfelmeier;Vijayveer Bonthapally

  • Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies

    Unknown

  • Postictal generalized electroencephalographic suppression is associated with generalized seizures

    Rainer Surges;Adam Strzelczyk;Adam Strzelczyk;Catherine A. Scott;Matthew C. Walker

  • Lacosamide in status epilepticus: Systematic review of current evidence

    Adam Strzelczyk;Adam Strzelczyk;Johann Philipp Zöllner;Laurent M. Willems;Julie Jost

  • Costs of epilepsy and cost‐driving factors in children, adolescents, and their caregivers in Germany

    Janna Riechmann;Adam Strzelczyk;Adam Strzelczyk;Jens P Reese;Rainer Boor

  • Progressive Postnatal Motoneuron Loss in Mice Lacking GDF-15

    Jens Strelau;Adam Strzelczyk;Patricia Rusu;Gerald Bendner

  • Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE).

    Christoph Kellinghaus;Andrea O. Rossetti;Eugen Trinka;Nicolas Lang

  • The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data.

    Adam Strzelczyk;Claudia Griebel;Wolfram Lux;Felix Rosenow;Felix Rosenow

  • Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability

    Unknown

  • Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany—a nationwide population-based study in children and adults

    Hajo M. Hamer;Richard Dodel;Adam Strzelczyk;Monika Balzer-Geldsetzer

  • Revised version of quality guidelines for presurgical epilepsy evaluation and surgical epilepsy therapy issued by the Austrian, German, and Swiss working group on presurgical epilepsy diagnosis and operative epilepsy treatment

    Felix Rosenow;Felix Rosenow;Thomas Bast;Thomas Czech;Martha Feucht

  • Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.

    Hajo M. Hamer;Annika Spottke;Christiane Aletsee;Susanne Knake

  • A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication

    Unknown

  • The history of invasive EEG evaluation in epilepsy patients.

    Philipp S. Reif;Adam Strzelczyk;Felix Rosenow;Felix Rosenow

  • Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.

    Isabel Steinig;Felix von Podewils;Gabriel Möddel;Sebastian Bauer;Sebastian Bauer

  • Reduced Rate of Inpatient Hospital Admissions in 18 German University Hospitals During the COVID-19 Lockdown.

    Lorenz Alois Kapsner;Marvin O. Kampf;Susanne A. Seuchter;Julian Gruendner

  • A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)

    Johann Philipp Zöllner;David Neal Franz;Christoph Hertzberg;Rima Nabbout

  • Comparison of minimally invasive and traditional surgical approaches for refractory mesial temporal lobe epilepsy: A systematic review and meta‐analysis of outcomes

    Konstantin Kohlhase;Johann Philipp Zöllner;Nitin Tandon;Adam Strzelczyk

  • Management and long-term outcome in patients presenting with ictal asystole or bradycardia.

    Adam Strzelczyk;Margarethe Cenusa;Sebastian Bauer;Hajo M. Hamer

  • KCNC3: phenotype, mutations, channel biophysics-a study of 260 familial ataxia patients.

    Karla P. Figueroa;Natali A. Minassian;Giovanni Stevanin;Giovanni Stevanin;Michael Waters

  • Inpatient treatment costs of status epilepticus in adults in Germany.

    Adam Strzelczyk;Susanne Knake;Wolfgang H. Oertel;Felix Rosenow

  • Evaluation of health-care utilization among adult patients with epilepsy in Germany.

    Adam Strzelczyk;Tanja Nickolay;Sebastian Bauer;Anja Haag

  • Prospective evaluation of a post-stroke epilepsy risk scale

    Adam Strzelczyk;Anja Haag;Hans Raupach;Gregor Herrendorf

Frequent Co-Authors

Felix Rosenow
Felix Rosenow Goethe University Frankfurt
Susanne Knake
Susanne Knake Philipp University of Marburg
Susanne Schubert-Bast
Susanne Schubert-Bast Goethe University Frankfurt
Karl Martin Klein
Karl Martin Klein University of Calgary
Hajo M. Hamer
Hajo M. Hamer University of Erlangen-Nuremberg
Wolfgang H. Oertel
Wolfgang H. Oertel Philipp University of Marburg
Thomas Bast
Thomas Bast Kork Epilepsy Center, Kehl-Kork
Eugen Trinka
Eugen Trinka Paracelsus Medical University
Richard Dodel
Richard Dodel University of Duisburg-Essen
Gerhard Kluger
Gerhard Kluger Paracelsus Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Adam Strzelczyk

Trending Scientists